1.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 10-038, NCT01200355
|
|
2.
|
Phase: Phase III Type: Supportive care Status: Active Age: 1 to 21 Sponsor: Other Protocol IDs: 06-08-367, NCT00726934
|
|
3.
|
Phase: Phase III Type: Supportive care Status: Active Age: Adult Sponsor: NCI, Other Protocol IDs: CDR0000633817, P30CA012197, CCCWFU-98608, IRB00007690, NCT00855309
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: DAPNEUT, NCT01216241
|
|
5.
|
Phase: Phase III Type: Supportive care Status: Active Age: 4 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000695718, COG-ACCL1031, ACCL1031, NCT01305200
|
|
6.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LA-EP06-302, NCT01516736
|
|
7.
|
Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: OHSU-2868, P30CA069533, 8507, SOL-04058-L, 2868, OHSU-8507, OHSU-SOL-04058-L, NCT00303849
|
|
8.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SPI-GCF-12-201, NCT01724866
|
|
9.
|
Phase: Phase I Type: Supportive care Status: Active Age: 18 to 60 Sponsor: Pharmaceutical / Industry Protocol IDs: TXA127-2010-001, NCT01300611
|
|
10.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 12D.214, 2012-35, NCT01660347
|